Publications
- Development of Resistant GvHD in a Patient Treated with Nivolumab for Hodgkins Lymphoma Relapse after Allogeneic Unrelated Transplantation2019 | Publication without faculty affiliation
- Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study2016 | First Faculty of Medicine
- Mesenchymal stem cells for the treatment of steroid refractory graft versus host disease after allogeneic stem cell transplantationPublication without faculty affiliation
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies2023 | Faculty of Medicine in Pilsen
- Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry2022 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Second Faculty of Medicine
- Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world2022 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome2019 | Faculty of Medicine in Pilsen
Loading network view...